文献速递流行病学与生物统计

印度结核病诊疗级联参与障碍:定量研究的系统综述

Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.
PubMed 文献 · PLoS Med · 2024-05-28

该研究系统综述了2000年1月1日至2023年8月14日PubMed、Embase和Web of Science中定量研究,识别印度结核病诊疗级联各环节不利结局的相关因素。男性、高龄、贫困、营养不良、饮酒、吸烟及对卫生服务不信任等因素与多个环节不利结局相关。复治患者更可能寻求诊疗但更易发生治疗前失访和不良治疗结局。

要点

  • 男性、高龄、贫困、营养不良、饮酒、吸烟和对卫生服务不信任与多个级联环节不利结局相关。
  • 复治结核患者更可能寻求诊疗但更易发生治疗前失访和不良治疗结局。
  • 缺乏结核知识、耻辱感、抑郁和药物不良反应与不良治疗结局相关。

核心结论

  • 该综述揭示了影响印度结核病患者结局的常见风险模式,并指出儿童结核病和私营部门结核病诊疗方面的知识空白,以指导未来研究。
  • 研究结果可能有助于针对不良结局高风险的结核病患者提供支持服务,并为多组分干预措施提供参考以弥合诊疗级联中的差距。

研究设计与样本

  • 遵循人群/暴露/比较/结局(PECO)框架的系统综述,检索PubMed、Embase和Web of Science从2000年1月1日至2023年8月14日。
  • 定义5个诊疗级联差距:未开始结核诊断检查(差距1)、未完成检查(差距2)、未开始治疗(差距3)、未达到治疗成功(差距4)、未达到无结核复发生存(差距5)。
  • 纳入评估各差距不利结局相关因素(以调整比值比、相对风险或风险比报告)和经历不利结局者原因(以比例报告)的文章。

主要发现

  • 与多个级联环节不利结局相关的因素包括男性、高龄、贫困相关因素、较低症状严重程度或持续时间、营养不良、饮酒、吸烟以及对卫生服务的不信任或不满。
  • 既往治疗过结核的人更可能寻求诊疗并参与诊断检查(差距1和2),但更可能发生治疗前失访(差距3)和不利治疗结局(差距4),尤其是既往治疗期间失访者。
  • 缺乏结核知识和结构性障碍(如交通困难)与结核症状不寻求诊疗相关(差距1,14项研究)。
  • 无法获得诊断(如X线)、未识别符合检测条件者和提供者未传达对结核的关切与未完成诊断检查相关(差距2,17项研究)。
  • 耻辱感、提供者对患者联系信息记录不佳和诊断延误导致的早期死亡与治疗前失访相关(差距3,15项研究);缺乏结核知识、耻辱感、抑郁和药物不良反应与不利治疗结局相关(差距4,86项研究);服药不依从与不利治疗结局(差距4)和结核复发(差距5,14项研究)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 因研究结果异质性未能进行Meta分析。
  • 鉴于印度人口多样性,研究结果对印度某些地区的普遍性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: India accounts for about one-quarter of people contracting tuberculosis (TB) disease annually and nearly one-third of TB deaths globally. Many Indians do not navigate all care cascade stages to receive TB treatment and achieve recurrence-free survival. Guided by a population/exposure/comparison/outcomes (PECO) framework, we report findings of a systematic review to identify factors contributing to unfavorable outcomes across each care cascade gap for TB disease in India. METHODS AND FINDINGS: We defined care cascade gaps as comprising people with confirmed or presumptive TB who did not: start the TB diagnostic workup (Gap 1), complete the workup (Gap 2), start treatment (Gap 3), achieve treatment success (Gap 4), or achieve TB recurrence-free survival (Gap 5). Three systematic searches of PubMed, Embase, and Web of Science from January 1, 2000 to August 14, 2023 were conducted. We identified articles evaluating factors associated with unfavorable outcomes for each gap (reported as adjusted odds, relative risk, or hazard ratios) and, among people experiencing unfavorable outcomes, reasons for these outcomes (reported as proportions), with specific quality or risk of bias criteria for each gap. Findings were organized into person-, family-, and society-, or health system-related factors, using a social-ecological framework. Factors associated with unfavorable outcomes across multiple cascade stages included: male sex, older age, poverty-related factors, lower symptom severity or duration, undernutrition, alcohol use, smoking, and distrust of (or dissatisfaction with) health services. People previously treated for TB were more likely to seek care and engage in the diagnostic workup (Gaps 1 and 2) but more likely to suffer pretreatment loss to follow-up (Gap 3) and unfavorable treatment outcomes (Gap 4), especially those who were lost to follow-up during their prior treatment. For individual care cascade gaps, multiple studies highlighted lack of TB knowledge and structural barriers (e.g., transportation challenges) as contributing to lack of care-seeking for TB symptoms (Gap 1, 14 studies); lack of access to diagnostics (e.g., X-ray), non-identification of eligible people for testing, and failure of providers to communicate concern for TB as contributing to non-completion of the diagnostic workup (Gap 2, 17 studies); stigma, poor recording of patient contact information by providers, and early death from diagnostic delays as contributing to pretreatment loss to follow-up (Gap 3, 15 studies); and lack of TB knowledge, stigma, depression, and medication adverse effects as contributing to unfavorable treatment outcomes (Gap 4, 86 studies). Medication nonadherence contributed to unfavorable treatment outcomes (Gap 4) and TB recurrence (Gap 5, 14 studies). Limitations include lack of meta-analyses due to the heterogeneity of findings and limited generalizability to some Indian regions, given the country's diverse population. CONCLUSIONS: This systematic review illuminates common patterns of risk that shape outcomes for Indians with TB, while highlighting knowledge gaps-particularly regarding TB care for children or in the private sector-to guide future research. Findings may inform targeting of support services to people with TB who have higher risk of poor outcomes and inform multicomponent interventions to close gaps in the care cascade.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Jhaveri TA, Jhaveri D, Galivanche A, et al. Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies. PLoS Med. 2024. PMID: 38805509. doi:10.1371/journal.pmed.1004409

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。